Alison Green

1.9k total citations · 1 hit paper
30 papers, 1.0k citations indexed

About

Alison Green is a scholar working on Molecular Biology, Neurology and Neurology. According to data from OpenAlex, Alison Green has authored 30 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 6 papers in Neurology and 6 papers in Neurology. Recurrent topics in Alison Green's work include Prion Diseases and Protein Misfolding (21 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (6 papers) and Neurological diseases and metabolism (6 papers). Alison Green is often cited by papers focused on Prion Diseases and Protein Misfolding (21 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (6 papers) and Neurological diseases and metabolism (6 papers). Alison Green collaborates with scholars based in United Kingdom, Italy and Germany. Alison Green's co-authors include Piero Parchi, Anna Ladogana, Maurizio Pocchiari, Inga Zerr, Richard Knight, Alessia Franceschini, Simone Baiardi, Sabina Capellari, Simon Mead and Jean‐Philippe Brandel and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Alison Green

27 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease

2021 171 citations Péter Hermann, Brian S. Appleby et al. The Lancet Neurology profile →

Peers

Countries citing papers authored by Alison Green

Since Specialization

Citations

This map shows the geographic impact of Alison Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Green more than expected).

Fields of papers citing papers by Alison Green

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Green. The network helps show where Alison Green may publish in the future.

Co-authorship network of co-authors of Alison Green

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Green. A scholar is included among the top collaborators of Alison Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Green. Alison Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Examining employees under stress by pandemic, hurricane, and bridge closure 2024 ·SHILAP Revista de lepidopterología ·(unknown), Alison Green, (unknown)	0
2	Improved Real-Time Quaking Induced Conversion for Early Diagnostics of Creutzfeldt–Jakob Disease in Denmark 2023 ·International Journal of Molecular Sciences ·(unknown), Eva Løbner Lund, (unknown), Mary Andrews, (unknown), Alison Green, (unknown)	0
3	Microbial production of the plant flavanone hesperetin from caffeic acid 2023 ·BMC Research Notes ·Erik K. R. Hanko, (unknown), (unknown), Alison Green, (unknown), (unknown), Cunyu Yan, Eriko Takano, Diana Lousa, Cláudio M. Soares, Rainer Breitling	5
4	CPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human saliva 2022 ·Journal of Medical Microbiology ·Enyia R. Anderson, Edward I. Patterson, (unknown), Ana K. Pitol, Thomas Edwards, (unknown), (unknown), Alison Green, Sayandip Mukherjee, Michael Hoptroff, Grant L. Hughes	17
5	The importance of ongoing international surveillance for Creutzfeldt–Jakob disease 2021 ·Nature Reviews Neurology ·Neil Watson, Jean‐Philippe Brandel, Alison Green, Péter Hermann, Anna Ladogana, (unknown), J. Mackenzie, Maurizio Pocchiari, Colin Smith, Inga Zerr, Suvankar Pal	76
6	Case report of homozygous E200D mutation of PRNP in apparently sporadic Creutzfeldt-Jakob disease 2021 ·BMC Neurology ·Ahamad Hassan, Tracy Campbell, Lee Darwent, (unknown), Alison Green, John Collinge, Simon Mead	6
7	Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease breakdown → 2021 ·The Lancet Neurology ·Péter Hermann, Brian S. Appleby, Jean‐Philippe Brandel, Byron Caughey, Steven Collins, Michael D. Geschwind, Alison Green, Stéphane Haı̈k, Gábor G. Kovács, Anna Ladogana, Franc Llorens, Simon Mead, Noriyuki Nishida, Suvankar Pal, Piero Parchi, Maurizio Pocchiari, Katsuya Satoh, Gianluigi Zanusso, Inga Zerr	171
8	Regional Differences in Neuroinflammation-Associated Gene Expression in the Brain of Sporadic Creutzfeldt–Jakob Disease Patients 2020 ·International Journal of Molecular Sciences ·(unknown), Thomas Litman, Helle Broholm, Linea Cecilie Melchior, (unknown), Alison Green, Jens Ole Eriksen, Colin Smith, Eva Løbner Lund	7
9	Diagnostic value of surrogate CSF biomarkers for Creutzfeldt–Jakob disease in the era of RT-QuIC 2019 ·Journal of Neurology ·Samir Abu‐Rumeileh, Simone Baiardi, Barbara Polischi, Angela Mammana, Alessia Franceschini, Alison Green, Sabina Capellari, Piero Parchi	43
10	Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies 2018 ·Acta Neuropathologica ·Paul A. De Sousa, Diane Ritchie, Alison Green, Siddharthan Chandran, Richard Knight, Mark Head	4
11	High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions 2017 ·Scientific Reports ·Alessia Franceschini, Simone Baiardi, Andrew G. Hughson, (unknown), Fabio Moda, Marcello Rossi, Sabina Capellari, Alison Green, Giorgio Giaccone, Byron Caughey, Piero Parchi	126
12	Imaging and CSF analyses effectively distinguish CJD from its mimics 2017 ·Journal of Neurology Neurosurgery & Psychiatry ·Peter Rudge, Harpreet Hyare, Alison Green, John Collinge, Simon Mead	70
13	Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease 2016 ·Science Translational Medicine ·Daisy Bougard, Jean‐Philippe Brandel, Maxime Bélondrade, Vincent Béringue, Christiane Segarra, Hervé Fleury, Jean Laplanche, (unknown), Simon Nicot, Alison Green, Arlette Welaratne, D. Narbey, Chantal Fournier‐Wirth, Richard Knight, Robert Will, Pierre Tiberghien, Stéphane Haı̈k, Joliette Coste	96
14	Prion seeding activity in cerebrospinal fluid from sporadic Creutzfeldt-Jakob disease patients using real-time QuIC analysis: a potential new diagnostic test? 2011 ·Prion ·Lynne I. McGuire, Alexander Peden, N. E. J. Appleford, Gary Mallinson, Christina D. Orrú, Jason M. Wilham, Gregory J. Raymond, Mary Andrews, Mark Head, Byron Caughey, (unknown), Richard Knight, Alison Green	2
15	The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt–Jakob disease 2009 ·Neuroscience Letters ·Catherine Pennington, (unknown), Jan Mackenzie, Mary Andrews, Robert Will, Richard Knight, Alison Green	33
16	Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies 2009 ·Journal of Neurology ·Anna Ladogana, Pascual Sánchez‐Juan, E Mitrová, Alison Green, Natividad Cuadrado‐Corrales, Raquel Sánchez‐Valle, (unknown), Adriano Aguzzi, Theodoros Sklaviadis, J Kulczycki, Joanna Gawinecka, Albert Saiz, Miguel Calero, Cornelia M. van Duijn, Maurizio Pocchiari, Richard Knight, Inga Zerr	51
17	Urinary α1-Antichymotrypsin: A Biomarker of Prion Infection 2008 ·PLoS ONE ·Gino Miele, Harald Seeger, Denis Marino, Ralf Eberhard, Mathias Heikenwälder, Katharina Stoeck, (unknown), Richard Knight, Alison Green, Francesca Chianini, Rudolf P. Wüthrich, Christoph Höck, Inga Zerr, Adriano Aguzzi	27
18	No evidence for association between taugene haplotypic variants and susceptibility to Creutzfeldt-Jakob disease 2007 ·BMC Medical Genetics ·Pascual Sánchez‐Juan, Matthew Bishop, Alison Green, (unknown), Alejandro Arias Vásquez, Anna Poleggi, Richard Knight, Cornelia M. van Duijn	10
19	Brain-derived proteins in the CSF, do they correlate with brain pathology in CJD? 2006 ·BMC Neurology ·(unknown), Walter Schulz‐Schaeffer, Monika Bodemer, Barbara Ciesielczyk, Bettina Meißner, Anna Krasnianski, (unknown), Uta Heinemann, Daniela Varges, Sabina Eigenbrod, Hans A. Kretzschmar, Alison Green, Inga Zerr	20
20	Uncontrolled Immigration and the U.S. Health Care System 2004 ·The Journal of social, political, and economic studies ·Alison Green, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact